Latest Articles

Publication Date
Less than half of UK endometriosis benefit payments awarded - South West Londoner

Less than half of UK endometriosis benefit payments awarded South West Londoner

Published: July 11, 2025, 8:47 a.m.
Women with PCOS, endometriosis and hyperthyroidism embrace matcha as TikTok highlights hormone health benefits - lbc.co.uk

Women with PCOS, endometriosis and hyperthyroidism embrace matcha as TikTok highlights hormone health benefits lbc.co.uk

Published: July 4, 2025, 12:56 p.m.
Selinexor Maintenance Offers Durable Benefit in Advanced Endometrial Cancer - Oncology Nursing News

Selinexor Maintenance Offers Durable Benefit in Advanced Endometrial Cancer Oncology Nursing News

Published: June 27, 2025, 6:10 p.m.
Selinexor Maintenance Displays Durable Benefit in TP53 Wild-Type Advanced/Recurrent Endometrial Cancer - OncLive

Selinexor Maintenance Displays Durable Benefit in TP53 Wild-Type Advanced/Recurrent Endometrial Cancer OncLive

Published: June 25, 2025, 9:58 p.m.
Endometrial Ablation Devices Market Size, Benefits, and Key Players - Latest Health Tech - openPR.com

Endometrial Ablation Devices Market Size, Benefits, and Key Players - Latest Health Tech openPR.com

Published: June 25, 2025, 6:07 a.m.
AZ redefines endometrial and ovarian cancer playbook - koreabiomed.com

AZ redefines endometrial and ovarian cancer playbook koreabiomed.com

Published: June 25, 2025, 12:05 a.m.
Cannabis 'works better than meds' for women with endometriosis, study finds - femalefirst.co.uk

Cannabis 'works better than meds' for women with endometriosis, study finds femalefirst.co.uk

Published: June 24, 2025, 12:55 p.m.
Top 10 Health Benefits of Regular Physical Activity - MSN

Top 10 Health Benefits of Regular Physical Activity MSN

Published: June 10, 2025, 9:16 a.m.
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer - Physician's Weekly

Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer Physician's Weekly

Published: June 10, 2025, 6:31 a.m.
Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer - HealthDay

Dostarlimab + Chemo Beneficial for Advanced, Recurrent Endometrial Cancer HealthDay

Published: June 9, 2025, 2:50 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!